These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 25432628)
21. WNT antagonist, SFRP1, is Hedgehog signaling target. Katoh Y; Katoh M Int J Mol Med; 2006 Jan; 17(1):171-5. PubMed ID: 16328026 [TBL] [Abstract][Full Text] [Related]
22. Silencing of secreted frizzled-related protein genes in MSI colorectal carcinogenesis. Tanaka J; Watanabe T; Kanazawa T; Tada T; Kazama Y; Tanaka T; Nagawa H Hepatogastroenterology; 2008; 55(85):1265-8. PubMed ID: 18795670 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Chim CS; Pang R; Fung TK; Choi CL; Liang R Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284 [TBL] [Abstract][Full Text] [Related]
24. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome. Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371 [TBL] [Abstract][Full Text] [Related]
25. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples. Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106 [TBL] [Abstract][Full Text] [Related]
26. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452 [TBL] [Abstract][Full Text] [Related]
27. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma. Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429 [TBL] [Abstract][Full Text] [Related]
28. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients. Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971 [TBL] [Abstract][Full Text] [Related]
29. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer. Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456 [TBL] [Abstract][Full Text] [Related]
30. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor]. Qi J; Zhu YQ; Luo J; Tao WH; Zhang JM Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):842-5. PubMed ID: 18396643 [TBL] [Abstract][Full Text] [Related]
31. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262 [TBL] [Abstract][Full Text] [Related]
32. Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Licchesi JD; Westra WH; Hooker CM; Machida EO; Baylin SB; Herman JG Carcinogenesis; 2008 May; 29(5):895-904. PubMed ID: 18308762 [TBL] [Abstract][Full Text] [Related]
33. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
34. DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes. Farkas SA; Vymetalkova V; Vodickova L; Vodicka P; Nilsson TK Epigenomics; 2014 Apr; 6(2):179-91. PubMed ID: 24811787 [TBL] [Abstract][Full Text] [Related]
36. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Ogino S; Kawasaki T; Kirkner GJ; Suemoto Y; Meyerhardt JA; Fuchs CS Gut; 2007 Nov; 56(11):1564-71. PubMed ID: 17339237 [TBL] [Abstract][Full Text] [Related]
37. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations. Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573 [TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368 [TBL] [Abstract][Full Text] [Related]
39. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968 [TBL] [Abstract][Full Text] [Related]
40. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]